TRGT13GORIG

Company

GYRE THERAPEUTICS, INC.

Filed

December 9, 2011

Accession Number

0001061768-11-000038

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →